Allergicheskiy rinit. Vozmozhnosti preventivnoy terapii


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Allergic rhinitis is a serious medical and social problem associated with a high morbidity and high economic expenses for rhinitis management. The conducted studies demonstrated expediency of treatment with intranasal steroids, the most suitable medication for a prevention strategy, because they target the inflammatory cascade at multiple points and yield measurable symptom relief when administered preventively.

Texto integral

Acesso é fechado

Sobre autores

A. Nasunova

O. Drobik

Bibliografia

  1. Meltzer EO, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 2009;30(3):244-54.
  2. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 2007;28(1):3-9.
  3. Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol 2010;125(2 Suppl. 2): 103-15.
  4. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 2008;63(10):1292-300.
  5. Wallace DV, et al. Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122(Suppl. 2):1-84.
  6. Connell JT. Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane. J Allergy 1968;41(3):123-39.
  7. Connell JT. Quantitative intranasal pollen challenges. III. The priming effect in allergic rhinitis. J Allergy 1969;43(1):33-44.
  8. Milanese M, et al. Eosinophils, specific hyperreactivity and occurrence of late phase reaction in allergic rhinitis. Eur Ann Allergy Clin Immunol 2005;37(1):7-10.
  9. Bousquet J, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl. 86): 8-160.
  10. Ariano R, et al. Possible role of climate changes in variations in pollen seasons and allergic sensitizations during 27 years. Ann Allergy Asthma Immunol 2010;104(3):215-22.
  11. Ziska L, et al. Recent warming by latitude associated with increased length of ragweed pollen season in central North America. Proc Natl Acad Sci USA 2011;108(10):4248-51.
  12. Ellis AK, et al. Factors that affect the allergic rhinitis response to ragweed allergen exposure. Ann Allergy Asthma Immunol 2010;104(4):293-8.
  13. Parker JD, et al. Air pollution and childhood respiratory allergies in the United States. Environ Health Perspect 2009;117(1):140-47.
  14. Sehlstedt M, et al. Airway inflammatory response to diesel exhaust generated at urban cycle running conditions. Inhal Toxicol 2010;22(14): 1144-50.
  15. Yoshizaki K, et al. Subchronic effects of nasally instilled diesel exhaust particulates on the nasal and airway epithelia in mice. Inhal Toxicol 2010;22(7):610-7.
  16. Ciprandi G, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995;96(6 pt 1):971-79.
  17. Braunstahl GJ, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107(3):469-76.
  18. Pelikan Z. Asthmatic response induced by nasal challenge with allergen. Int Arch Allergy Immunol 2009;148(4):330-38.
  19. Crystal-Peters J, et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002;109(1):57-62.
  20. Bousquet J, et al. Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl. 5):147-334.
  21. Lack G, et al. The link between otitis media with effusion and allergy: a potential role for intranasal corticosteroids. Pediatr Allergy Immunol 2011;22(3):258-66.
  22. Marple BF. Targeting congestion in allergic rhinitis: the importance of intranasal corticosteroids. Allergy Asthma Proc 2008;29(3):232-40.
  23. Meltzer EO. The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids. Allergy. 1997;52(Suppl 36):33-40.
  24. Frieri M, et al. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1998;81(5 pt 1):431-37.
  25. Pitsios C, et al. Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2006;96(5):673-78.
  26. Bousquet J, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, doubleblind, double-dummy, parallel-group study. Allergy 1993;48(5):327-33.
  27. Juniper EF, et al. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989;83(3):627-33.
  28. Blaiss MS. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc 2007; 28(2):145-52.
  29. Meltzer EO, et al. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies. Clin Drug Investig 2009; 29(2):79-86.
  30. Nasonex prescribing information. Whitehouse Station, NJ: Merck & Co., Inc; 2011.
  31. Veramyst prescribing information. Research Triangle Park, NC: GlaxoSmithKline; 2011.
  32. Bielory L, et al. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis. Allergy 2011;66(5):686-93.
  33. Baiardini I, et al. Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. Clin Exp Allergy 2011;41(3):417-23.
  34. Fromer L, et al. Assessment of patient attitudes about mometasone furoate nasal spray: The Ease-of-Use Patient Survey. World Allergy Organiz J 2008;1(9):156-59.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2013

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies